Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Array BioPharma Inc. announced that a poster on ARRY–403, a novel, oral, glucokinase activator, will be presented at the European Association for the Study of Diabetes annual meeting, on October 2009, in Vienna, Austria. The poster will provide preclinical and Phase 1 single ascending dose clinical data on ARRY–403.

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address